What Is VESTAKEEP M-Bead?
Evonik VESTAKEEP M-Bead is a medical-grade polyether ether ketone (PEEK) specifically engineered for implantable medical device applications. The “M-Bead” designation refers to the bead form — small, spherical PEEK granules optimised for compression moulding, direct compression processing, and selective laser sintering (SLS) additive manufacturing of implantable structures. Unlike standard PEEK granules used for injection moulding, M-Bead’s spherical morphology, tight particle size distribution, and controlled surface chemistry make it suitable for the manufacturing routes used in the medical device industry, where process reproducibility and material purity are as critical as the polymer’s intrinsic properties. VESTAKEEP is Evonik’s brand name for their PEEK portfolio, and M-Bead is positioned specifically for customers in spinal, orthopaedic, and cardiovascular device manufacturing who need a PEEK material with a complete regulatory package, implant-grade traceability, and documented biocompatibility.
Medical-Grade Biocompatibility and Regulatory Status
VESTAKEEP M-Bead is supplied with a comprehensive regulatory package that represents its primary competitive advantage over standard industrial PEEK grades. The material has been tested to the full ISO 10993 battery for long-term implantable devices, including: cytotoxicity (ISO 10993-5), sensitisation (ISO 10993-10), irritation (ISO 10993-10), systemic toxicity (ISO 10993-11), pyrogenicity, and implantation testing. The full test battery is documented in Evonik’s Technical Data Package (TDP) which supports 510(k), PMA, and CE marking submissions. Evonik also holds a Drug Master File (DMF) with the FDA, allowing device manufacturers to reference Evonik’s testing data in their own regulatory submissions rather than repeating the full battery themselves — a significant cost and time saving. VESTAKEEP M-Bead is also listed in the EU MDR Technical Documentation under the relevant material classification, supporting CE marking for devices sold in the European market. Procurement teams evaluating PEEK for implantable applications should request the full TDP and confirm the specific grade and batch certifications match the device’s regulatory submission.
Mechanical Properties for Orthopaedic and Spinal Applications
The mechanical properties of VESTAKEEP M-Bead are specifically validated for load-bearing implantable use. Tensile strength is approximately 90–100 MPa, with a tensile modulus of approximately 3.6 GPa — deliberately close to the modulus of human cortical bone (approximately 15–20 GPa for cortical bone, but PEEK’s compliance reduces stress shielding at the implant-bone interface compared to titanium alloys, which is a key clinical advantage). Elongation at break is in the 20–40% range, providing toughness that is superior to ceramics and acceptable for most non–structural load-bearing implant configurations. Fatigue performance is a critical property for spinal cage and orthopaedic load-bearing applications: VESTAKEEK has demonstrated >10⁷ cycle fatigue life at physiological stress levels in documented testing. The material’s radiolucency allows clear visualisation of the healing process on X-ray and CT without metal artefact, another significant clinical advantage over metallic implants. For CT and MRI compatibility, PEEK is MRI safe (non-ferromagnetic, non-electrically conductive) and does not produce imaging artefacts of the magnitude generated by titanium or cobalt-chrome.
Spinal Implant Applications
PEEK spinal cages represent the single largest volume application for VESTAKEEP M-Bead. Interbody fusion cages made from PEEK-OPTIMA (Invibio’s competing grade, also widely used) or VESTAKEEP offer a radiolucent alternative to titanium cages, allowing clearer assessment of fusion progress on postoperative imaging. The modulus of PEEK, being lower than metal, reduces the stress shielding effect that can lead to bone resorption around metallic implants. VESTAKEEP M-Bead’s implant-grade purity and documented biostability mean it does not degrade, swell, or release harmful byproducts within the body over the multi-year implantation periods typical of spinal fusion devices. Surface modification options — plasma treatment, titanium coating (for osseointegration), and hydroxyapatite coating — are compatible with VESTAKEEK and widely used in commercial spinal cage designs. For buyers sourcing PEEK for spinal cage manufacturing, the surface treatment and coating compatibility of the specific PEEK grade must be confirmed with the material supplier before BOM lock.
Cardiovascular and Other Implantable Uses
Beyond spinal applications, VESTAKEEP M-Bead is used in cardiovascular devices including pacing lead insulators, heart valve components, and closure device frames. In these applications, the material’s thromboresistance, flexibility, and long-term biostability are critical. The bead form enables manufacturing processes for braided and woven vascular devices, and the material’s melt processing window is compatible with catheter-based manufacturing equipment. Orthopaedic trauma plates and screws use VESTAKEEK as a composite component in hybrid metal-PEEK fixation systems, where the PEEK elements reduce the overall modulus mismatch between implant and bone. Dental implant abutments and provisional prosthetics represent a smaller but growing market segment, where PEEK’s aesthetics (available in tooth-coloured options), biocompatibility, and low plaque affinity are clinically valued.
Supply Chain, Pricing, and Qualification
VESTAKEEP M-Bead is supplied by Evonik with full implant-grade traceability, including lot-specific COA, certificate of origin, and regulatory documentation. Pricing for medical-grade PEEK in bead form is significantly higher than industrial-grade equivalents — a multiple of 3–5x over standard injection moulding PEEK granules — reflecting the additional quality control, testing, and regulatory documentation investment. Minimum order quantities are typically 5–25 kg for sampling and qualification; production quantities follow negotiated annual supply agreements with quality and pricing commitments. Lead times for qualified grades are typically 4–8 weeks from Evonik, with authorised distributors holding limited domestic stock for common grades. For new device programs, the material qualification timeline (including biocompatibility testing, device testing, and regulatory submission) typically runs 18–36 months before commercial production — the material supply itself rarely drives the critical path, but supply chain qualification should begin at the device design concept stage.
Quality Assurance and Lot Traceability
Medical device manufacturers sourcing VESTAKEEP M-Bead should implement incoming lot verification including: tensile testing against specification minimums, moisture content verification (<0.2% recommended for compression moulding), and visual inspection of bead morphology. The certificate of analysis should be cross-referenced against the Evonik material specification sheet and the device manufacturer's approved material qualification. For devices requiring regulatory submission, maintain the full chain of custody documentation — the relationship between the device 510(k)/PMA and the specific material lot used in the manufactured device must be traceable for audits and post-market surveillance. Evonik provides a Medical Device Technical Package that includes design guidance, processing recommendations, and regulatory support documentation that is typically covered under a technical agreement with the customer.
Strategic Procurement Guidance
For medical device manufacturers, VESTAKEEP M-Bead represents a low-risk, fully documented path to implant-grade PEEK procurement. The investment in Evonik’s regulatory package is justified for devices targeting FDA 510(k) or PMA clearance, where the ability to reference an existing DMF and full ISO 10993 test battery reduces both cost and timeline. For early-stage device programs still in prototype, it is worth engaging Evonik’s technical team early to confirm bead processing requirements and surface treatment compatibility. The supply chain relationship matters: establish a technical quality agreement (TQA) with Evonik or an authorised distributor before the device enters pivotal trials, to lock in supply continuity and pricing for the regulatory and commercial phases.